Notably, miR-125b was able to accurately discriminate among all NSCLC stages [73], whereas the miR-301 + miR-200b + miR-193b + miR-141 [107] and miR-125a-5p + let-7e + CEA panels [101] specifically distinguished early-stage NSCLC patients. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.